Introduction
Biological warfare (BW) agents infect the body via the same portals of entry as infectious organisms that occur naturally. These include inhalation into the respiratory tract; ingestion into the gastrointestinal tract; and absorption through mucous membranes, eyes, skin, or wounds. Most BW agents will enter the body through inhalation. Usually, the disease produced by a BW agent will mimic the naturally occurring disease, but the clinical presentation can be different if delivery of an agent occurs through a portal that differs from the natural portal.
Detection
 The appearance of a large outbreak of cases of a similar disease or syndrome, especially in a discrete population.  Many cases of unexplained diseases or death.  More severe disease than is usually expected for a specific pathogen or failure to respond to a standard therapy.  Unusual routes of exposure for a pathogen, such as the inhalation route of diseases that normally occur through other exposures.  A disease case or cases that are unusual for a given geographic area or transmission season.  Disease normally transmitted by a vector that is not present in the local area. Hemorrhagic Fevers-Hanta, Ebola, Lassa, Rift Valley, and Hemorrhagic Fever With Renal Syndrome  These viruses pose special challenges for hospital infection control. With the exception of dengue and hantaviruses, viral hemorrhagic fever patients harbor significant levels of potentially infectious virus in blood, body fluids, or secretions. Special caution must be exercised in handling hypodermic needs and other sharps. Strict adherence to standard and contact precautions will prevent nosocomial transmission in most cases.  When a viral hemorrhagic fever is suspected, additional infection control measures are indicated. The patient should be isolated in a private room with an adjoining anteroom to be used for donning and doffing protective barrier garments, storage of supplies, and decontamination of lab specimen containers.  Medical evacuation may result in increased morbidity and mortality; thus, treatment at local medical treatment facilities is preferred.  When necessary, patients may be evacuated using universal and respiratory droplet isolation precautions.
Biological Agents
The four toxins most likely to be used as biological agents are botulinum toxins, ricin, staphylococcal enteroxin B, and T-2 mycotoxins (Table 29-1) . 
Bacterial Agents
The bacteria or rickettsia most often considered to be potential BW threat agents include Bacillus anthracis (anthrax), Brucella sp. (brucellosis), Vibrio cholerae (cholera), Burkholderia mallei (glanders), Yersinia pestis (plague), Francisella tularensis (tularemia), and Coxiella burnetii (Q fever) (Table 29 -2). 
Viral Agents
A number of viruses are BW agents, including smallpox, viral hemorrhagic fevers, and the alpha virus that causes Venezuelan equine encephalitis (Table 29-3) . 
